AdlerD.D.: Mammographic evaluation of masses. In: Syllabus: a categorical course in breast imagingKopansD.B., MendelsonE.B., Eds., pp. 107–116, RSNA Publication, Oak Brook, IL, 1995.
2.
AdlerL.P., CroweJ.P., AI-KaisiN.K., SunshineJ.L.: Evaluation of breast masses and axillary lymph nodes with 18-F2 deoxy-2-fluoro-d-glucose PET. Radiology, 187: 743–750, 1993.
3.
AzavedoE., SvaneG., AuerG.: Stereotactic fine-needle biopsy in 2,594 mammographically detected non palpable lesions. Lancet, 1: 1033–1036, 1989.
4.
CiattoS., Rosselli Del TurcoM., BravettiP.: Nonpalpable breast lesions: stereotaxic fine-needle aspiration cytology. Radiology, 173: 57–59, 1989.
5.
ColemanR.E., RubensR.D., FogelmanI.: Reappraisal of the baseline bone scan in breast cancer. Nucl. Med., 29: 1045–1049, 1988
6.
DoneganW.L.: Evaluation of palpable breast masses. N. Engl. J. Med., 327: 937–942, 1992.
7.
D'OrsiC.J., RealeF.R., DavisM.A., BrownV.J.: Breast specimens in microcalcifications: radiologic validation and pathologic-radiologic correlation. Radiology, 180: 397–401, 1991.
8.
FajardoL.L., DavisJ.R., WiensJ.L., TregoD.C.: Mammography-guided stereotactic fine-needle aspiration cytology of non palpable breast lesions: prospective comparison with surgical biopsy results. A.J.R., 155: 977–981, 1990.
9.
GordonI., PetersA.M., GutmanA., MoronyS., Dicks-MireayxC., PritchardJ.: Technetium-99m bone scans are more sensitive than 1-123-MIBG scans for bone imaging in neuroblastoma. J. Nucl. Med., 31: 129–134, 1990.
10.
GordonP.B.: US for problem solving in breast imaging: tricks of the trade. In: Syllabus: a categorical course in breast imaging, KopansD.B., MendelsonE.B., Eds, pp. 121–131, RSNA Publication, Oak Brook, IL1995.
11.
HollandR., HendriksJ.H.C.L.: Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation. Semin. Diagn. Pathol., 11: 181–192, 1994.
12.
KaiserW.A., ZeitlerE.: MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Radiology, 170: 681–686, 1989.
13.
KhalkhaliI., CutroneJ.A., MenaI., DigglesL., VenegasR., VargasH., JacksonB., KleinS.: Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up. J. Nucl. Med., 36: 1784–1789, 1995.
14.
KhalkhaliI., CutroneJ.A., MenaI., DigglesL.E., VenegasR.J., VargasH.I., JacksonB.L., KhalkhaliS., MossJ.F., KleinS.R.: Scintimammography: the complementary role of Tc-99m sestaMIBI prone breast imaging for the diagnosis of breast carcinoma. Radiology, 196: 421–426, 1995.
15.
LafontanB., DauresJ.P., SalieruB., EyniusF., MihuraJ., RouanetP., LamarqueJ.L., NajaA., PujolH.: Isolated clustered microcalcifications: diagnostic value of mammography - series of 400 cases with surgical verification. Radiology, 190: 479–483, 1994.
16.
LastoriaS., VarreliaP., MainolfiC., VergaraE., MaureaS., AcampaW., PiccoloS., SalvatoreM.:Tc-99m sestaMIBI scintigraphy in the diagnosis of primary breast cancer. J. Nucl. Med., 35: 22P, 1994.
17.
LastoriaS., PiccoloS., VarreliaP., AcampaW., MainolfiC., VergaraE., WangH., MutoP., SalvatoreM.:Comparative results of technetium-99m MIBI and Technetium-99m methylene diphosphonate scintimammography in patients with breast abnormalities. J. Nucl. Med., 36: 51P, 1995.
18.
LeeV.W., SaxE.J., McAnenyD.B., PollackS., BlanchardR.A., BeazleyR.M., KavanahM.T., WardR.J.: A complementary role for thallium-201 scintigraphy with mammography in the diagnosis of breast cancer. J. Nucl. Med., 34: 2095–2100, 1993.
19.
Lev-ToaffA.S., FeigS.A., SaitasV.L., FinkelG.C., SchwartzG.F.: Stability of malignant breast microcalcifications. Radiology, 192: 153–156, 1994.
20.
MansiL., RambaldiP., La ProviteraA., Di GregorioF., ProcacciniE.:Technetium-99M tetrofosmin uptake in breast tumors. J. Nucl. Med., 36: 83P, 1995.
21.
MaublantJ., de LatourM., MestasD., ClemensonA., CharrierS., FeillelV., Le BouedecG., KauffmannP., DauplatJ., VeyrcA.: Technetium-99m-sestaMIBI uptake in breast tumors and associated lymph nodes. J. Nucl. Med., 1996
MoskowitzM.: Minimal breast cancer, redux. Radiol. Clin. North Am., 21: 93–113, 1983.
24.
PiccoloS., LastoriaS., MainolfiC., MutoP., BazzicalupoL., SalvatoreM.: Technetium-99m-methylene diphosphonate scintimammography to image primary breast cancer. J. Nucl. Med., 36: 718–724, 1995.
25.
RosenbergA.L., SchwartzG.F., FeigS.A., PatchefskyA.S.: Clinically occult breast lesions: localizations and significance. Radiology, 162: 167–170, 1987.
26.
Ross McDougallI., PistenmaD.A.: Concentration of 99mTc-diphosphonate in breast tissue. Radiology, 112: 655–657, 1974.
27.
SickelsE.A.: Breast masses: mammographic evaluation. Radiology, 173: 297–303, 1989.
28.
SicklesE.A.: Management of probably benign lesions. In: Syllabus: a categorical course in breast imaging, KopanD.B., MendelsonE.B., Eds., pp. 133–138, RSNA Publication, Oak Brook, IL, 1995.
29.
TailleferR., RobidouxA., LambertR., TurpinS., LaperriéreJ.: Technetium 99m-sestaMIBI prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J. Nucl. Med., 36: 1758–1765, 1995.
30.
TeixidorH.S., WojsatekD.A., ReichesE.M., Santos-BuchC.A., MinickC.R.: Fine-needle aspiration of breast biopsy specimens: correlation of histologic and cytologic findings. Radiology, 184: 55–58, 1992.
31.
Van EijckC., KrenningE., BootsamaA., OetH., van PelR.: Somatostatin receptor scintigraphy in primary breast cancer. Lancet, 343: 640–643, 1994.
32.
WaxmanA.D., RamannaL., MemsieL.D., FosterC.E., SilbermanA.W., GleischmanS.H., BrennerR.J., BrachmanM.B., KuharC.J., YadegarJ.: Thallium scintigraphy in the evaluation of mass abnormalities of the breast. J. Nucl. Med., 34: 18–23, 1993.